| |
| |
|
| Insider
Information: |
Squicciarino Joseph |
| Relationship: |
Director |
| City: |
Bristol |
| State: |
TN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
0 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
King Pharmaceuticals Inc |
KG |
Chief Financial Officer |
2011-01-31 |
0 |
2005-10-18 |
0 |
Premium* |
|
|
Zep Inc |
ZEP |
Director |
2015-06-26 |
0 |
2007-11-14 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
34 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2005-10-18 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
100,000 |
|
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2006-03-20 |
4 |
A |
$0.00 |
$0 |
D/D |
11,790 |
111,790 |
|
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2006-10-02 |
4 |
AS |
$17.03 |
$569,638 |
D/D |
(33,333) |
78,457 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2007-03-21 |
4 |
A |
$0.00 |
$0 |
D/D |
13,870 |
92,327 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2007-05-15 |
4 |
A |
$0.00 |
$0 |
D/D |
105,500 |
197,827 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2007-07-03 |
4 |
AS |
$20.78 |
$415,761 |
D/D |
(20,000) |
177,827 |
0 |
- |
|
| ZEP |
Zep Inc |
Director |
– • – |
2007-11-14 |
4 |
A |
$0.00 |
$0 |
D/D |
11,980 |
11,980 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2007-12-14 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
257,827 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2008-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
21,370 |
279,197 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2008-06-27 |
4 |
D |
$10.26 |
$130,128 |
D/D |
(12,683) |
266,514 |
0 |
- |
|
| ZEP |
Zep Inc |
Director |
– • – |
2008-09-29 |
4 |
A |
$0.00 |
$0 |
D/D |
570 |
12,550 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2008-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
29,460 |
295,974 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2009-01-16 |
4 |
A |
$0.00 |
$0 |
D/D |
5,345 |
301,319 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2009-03-10 |
4 |
D |
$6.31 |
$79,834 |
D/D |
(12,652) |
288,667 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2009-03-20 |
4 |
D |
$6.80 |
$29,145 |
D/D |
(4,286) |
284,381 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2009-03-23 |
4 |
A |
$0.00 |
$0 |
D/D |
27,520 |
311,901 |
0 |
- |
|
| ZEP |
Zep Inc |
Director |
– • – |
2009-09-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,329 |
15,879 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2009-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
32,220 |
344,121 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-03-10 |
4 |
D |
$12.22 |
$143,121 |
D/D |
(11,712) |
332,409 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-03-17 |
4 |
A |
$0.00 |
$0 |
D/D |
25,850 |
358,259 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-03-22 |
4 |
D |
$12.25 |
$61,765 |
D/D |
(5,042) |
353,217 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-03-22 |
4/A |
D |
$12.25 |
$68,992 |
D/D |
(5,632) |
352,627 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-12-14 |
4 |
D |
$14.22 |
$527,278 |
D/D |
(37,080) |
315,547 |
0 |
- |
|
| KG |
King Pharmaceuticals Inc |
Chief Financial Officer |
• – – |
2010-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
74,820 |
422,427 |
0 |
- |
|
| ZEP |
Zep Inc |
Director |
– • – |
2011-01-06 |
4 |
A |
$0.00 |
$0 |
D/D |
2,688 |
18,567 |
0 |
- |
|
34 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
